SEC Filing Summary: Westwood Holdings Group Inc.
Business Context and Reporting Period
Filing Type: Form 13F Information Table
Company: Westwood Holdings Group Inc.
Reporting Period: Quarter ended March 31, 2024
Context: This filing discloses the equity securities held by Westwood Holdings Group Inc. as a registered investment adviser. The document lists individual holdings, share counts, and voting authority but does not contain the company's own operational financial statements (revenue, profit, cash flow).
Key Financial Metrics and Portfolio Composition
Portfolio Overview: The filing details a diversified portfolio of common stocks, preferred stocks, and corporate bonds. Specific aggregate portfolio value is not explicitly stated as a single line item, but individual position values are provided.
- Top Equity Holdings (by Value):
- Microsoft Corp: $227,596,000 (540,969 shares)
- JPMorgan Chase & Co: $183,347,000 (915,363 shares)
- Bank of America Corp: $156,556,000 (4,128,597 shares)
- Johnson & Johnson: $149,487,000 (944,983 shares)
- Abbott Labs: $137,849,000 (1,212,815 shares)
- Notable Fixed Income Holdings:
- Exact Sciences Corp (0.375% Note): $8,385,000
- Akamai Technologies Inc (0.125% Note): $8,888,000
- Northern Oil & Gas Inc (3.625% Note): $7,115,000
- Live Nation Entertainment (3.125% Note): $6,617,000
- ETF Exposure: Significant holdings in broad market ETFs including Invesco QQQ Trust, iShares Core S&P 500 ETF, and various Vanguard index funds.
Material Changes and Voting Authority
Voting Authority: Westwood Holdings Group Inc. reports "Sole" voting authority for the majority of its equity positions. "Shared" voting authority is reported for select positions (e.g., 10X Genomics, Alphabet, Amazon), while "None" is reported for specific holdings (e.g., American Coastal Ins Corp, IShares Gold Trust).
Comparison to Prior Period: The filing text provided does not include comparative data from the previous quarter (December 31, 2023). Therefore, material changes in position size or new entries cannot be quantified from this document alone.
Guidance, Outlook, and Risks
Management Commentary: Form 13F filings are statutory disclosures of holdings and do not contain management commentary, forward-looking guidance, or strategic outlooks.
Risks and Contingencies: The filing includes a standard SEC disclaimer stating that the Commission has not reviewed the information for accuracy. The portfolio is exposed to market volatility across multiple sectors including Technology, Financials, Healthcare, and Energy. Significant exposure to specific corporate bonds implies credit risk associated with those issuers.
Investor Verification Checklist
- Portfolio Concentration: Verify the total aggregate value of the portfolio to assess concentration risk relative to the firm's total assets under management.
- Turnover Analysis: Compare this March 31, 2024 list against the December 31, 2023 filing to identify significant buy/sell activity.
- Fixed Income Exposure: Review the credit ratings of the specific corporate bonds held (e.g., Exact Sciences, Akamai) to assess credit risk.
- Derivatives: Note the presence of "Put" and "Call" columns; while mostly empty in this text, verify if any derivative positions were omitted or reported under different CUSIPs.
- Shared Authority: Investigate the nature of "Shared" voting authority positions to understand potential co-investment structures.